Clinical trial Recruiting at 1 site Interventional Ages 50 to 90

Repositioning the peeled inner limiting membrane to treat macular holes

Official title: PEELED INTERNAL LIMITING MEMBRANE REPOSITION FOR IDIOPATHIC MACULAR HOLES: A Single-centre, Randomized, Prospective Controlled Trial

Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT06359548 · Data updated 2026-11-12

This study is testing a new surgery that moves a part of the eye to help close macular holes in older patients, instead of removing it like usual.

More Macular Holes trials

Quick facts

Study typeInterventional
Ages50 Years to 90 Years
SexAll
Enrollment90 (estimated)
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedApril 15, 2024
Main results expectedJune 2026
Study endsNovember 2026
Registry record updatedApril 11, 2024
Trial IDNCT06359548 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 50 to 80 years with a diagnosed macular hole measuring 600 µm or less.

Probably not a fit

Patients with traumatic macular holes or other serious ocular conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates a novel surgical technique for treating macular holes by repositioning the peeled inner limiting membrane (ILM) instead of the conventional ILM peeling method. The approach aims to preserve the integrity of the internal retina while effectively closing the macular hole. Patients aged 50 to 80 years diagnosed with macular holes of a specific size will be recruited for this intervention. The study seeks to evaluate the effectiveness and safety of this new technique compared to traditional methods.

Why it matters

Potential benefit: If successful, this technique could improve visual outcomes and quality of life for patients with macular holes.

How similar studies have gone: Previous pilot studies have suggested that this novel approach may achieve better morphological and functional outcomes compared to traditional ILM peeling.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. The patients are diagnosed as MH with a diameter ≤ 600 µm by optical coherence tomography.
2. Age ranges from 50 to 80 years.
3. Do not participate in other clinical studies.
4. Agree to sign an informed consent form with good compliance.

Exclusion Criteria:

1. Traumatic macular hole.
2. Combined with serious epiretinal membrane.
3. Combined with diabetic retinopathy, hypertensive retinopathy.
4. Combined with other ocular diseases, such as keratitis,uveitis,retinal vasculitis.
5. Spherical equivalent ≥ -6.0 diopters or axial length ≥ 26 mm.
6. History of intraocular surgery.
7. Presence of staphyloma.
8. Other ocular diseases that influence macular microstructure or visual function.

Where it's running

  • Xinhua Hospital Affiliated to Shanghai Jiaotong University Medicine School
    Shanghai, China
    Recruiting

Study contacts

  • Principal investigator: Tian Tian, MD,PhD — Xinhua Hospital, Shanghai Jiaotong University School of Medicine
  • Study coordinator: Tian Tian, MD,PhD
  • Email: tiantianoph@163.com
  • Phone: +8615216695095

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.